Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jung Choi. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jung Choi har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:GBT / Global Blood Therapeutics Inc. | See Remarks | 0 |
US:ANNX / Annexon, Inc. | Director | 10 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jung Choi. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ANNX / Annexon, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ANNX / Annexon, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ANNX / Annexon, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jung Choi som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-10-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | −25 000 | 0 | −100,00 | ||||
2022-10-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | −226 672 | 0 | −100,00 | ||||
2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
G - Gift | −73 855 | 226 672 | −24,58 | ||||
2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 674 | 300 527 | 0,90 | 3,40 | 9 092 | 1 021 792 | |
2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 674 | 300 527 | 0,90 | 3,40 | 9 092 | 1 021 792 | |
2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 74 964 | 295 179 | 34,04 | 3,40 | 254 878 | 1 003 609 | |
2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 275 | 220 215 | 1,04 | 65,82 | 149 740 | 14 494 551 | |
2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 16 902 | 217 940 | 8,41 | 16,40 | 277 193 | 3 574 216 | |
2022-09-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −1 861 | 201 038 | −0,92 | 68,15 | −126 827 | 13 700 740 | |
2022-09-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 208 | 202 899 | 1,10 | ||||
2022-09-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 763 | 200 691 | 1,40 | ||||
2022-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −2 126 | 197 928 | −1,06 | 32,40 | −68 882 | 6 412 867 | |
2022-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 6 145 | 200 054 | 3,17 | ||||
2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to buy) |
A - Award | 28 628 | 28 628 | |||||
2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 17 668 | 17 668 | |||||
2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 17 668 | 17 668 | |||||
2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 763 | 16 577 | −14,29 | ||||
2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −956 | 191 374 | −0,50 | 29,87 | −28 556 | 5 716 341 | |
2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 763 | 192 330 | 1,46 | ||||
2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 020 | 12 080 | −20,00 | ||||
2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 125 | 6 250 | −33,33 | ||||
2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 0 | −100,00 | ||||
2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −3 340 | 189 567 | −1,73 | 29,33 | −97 962 | 5 560 000 | |
2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 9 020 | 192 907 | 4,91 | ||||
2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 020 | 15 100 | −16,67 | ||||
2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 125 | 9 375 | −25,00 | ||||
2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 2 875 | −50,00 | ||||
2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −3 743 | 182 367 | −2,01 | 27,33 | −102 296 | 4 984 090 | |
2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 9 020 | 186 110 | 5,09 | ||||
2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 762 | 19 340 | −12,50 | ||||
2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −1 370 | 183 887 | −0,74 | 29,85 | −40 894 | 5 489 027 | |
2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 762 | 185 257 | 1,51 | ||||
2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 128 | 182 495 | 0,07 | 24,39 | 3 122 | 4 451 053 | |
2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 020 | 15 100 | −16,67 | ||||
2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 125 | 9 375 | −25,00 | ||||
2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 2 875 | −50,00 | ||||
2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −3 743 | 182 367 | −2,01 | 27,33 | −102 296 | 4 984 090 | |
2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 9 020 | 186 110 | 5,09 | ||||
2021-06-04 |
|
4 | ANNX |
Annexon, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2021-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 22 102 | 22 102 | |||||
2021-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 38 739 | 38 739 | |||||
2021-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 140 | 177 090 | 0,08 | 36,21 | 5 069 | 6 412 429 | |
2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 020 | 18 120 | −14,29 | ||||
2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 125 | 12 500 | −20,00 | ||||
2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 5 750 | −33,33 | ||||
2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 063 | 0 | −100,00 | ||||
2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −4 646 | 176 950 | −2,56 | 49,49 | −229 931 | 8 757 256 | |
2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 13 083 | 181 596 | 7,76 | ||||
2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 020 | 21 140 | −12,50 | ||||
2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 125 | 15 625 | −16,67 | ||||
2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 8 625 | −25,00 | ||||
2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 062 | 4 063 | −49,99 | ||||
2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −6 239 | 168 513 | −3,57 | 67,48 | −421 008 | 11 371 257 | |
2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 13 082 | 174 752 | 8,09 | ||||
2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 162 | 161 670 | 0,10 | 36,68 | 5 942 | 5 930 056 | |
2020-06-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 42 400 | 42 400 | |||||
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 38 500 | 38 500 | |||||
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 24 160 | 24 160 | |||||
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 125 | 18 750 | −14,29 | ||||
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 11 500 | −20,00 | ||||
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 063 | 8 125 | −33,34 | ||||
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −3 570 | 161 508 | −2,16 | 65,26 | −232 978 | 10 540 012 | |
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 10 063 | 165 078 | 6,49 | ||||
2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 286 | 155 015 | 0,18 | 36,68 | 10 490 | 5 685 950 | |
2019-12-17 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2019-12-17 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −2 479 | 154 729 | −1,58 | 76,88 | −190 586 | 11 895 566 | |
2019-12-17 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 5 000 | 157 208 | 3,28 | ||||
2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 125 | 21 875 | −12,50 | ||||
2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 14 375 | −16,67 | ||||
2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 062 | 12 188 | −25,00 | ||||
2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −3 990 | 152 208 | −2,55 | 54,25 | −216 458 | 8 257 284 | |
2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 10 062 | 156 198 | 6,89 | ||||
2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 285 | 146 136 | 0,20 | 36,68 | 10 454 | 5 360 268 | |
2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 000 | 5 000 | −28,57 | ||||
2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −692 | 145 851 | −0,47 | 58,51 | −40 489 | 8 533 742 | |
2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 146 543 | 1,38 | ||||
2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 269 | 144 543 | 0,19 | 36,68 | 9 867 | 5 301 837 | |
2019-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 277 | 144 274 | 0,19 | 35,53 | 9 842 | 5 126 055 | |
2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 17 250 | −14,29 | ||||
2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 063 | 16 250 | −20,00 | ||||
2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 25 000 | 25 000 | |||||
2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 40 000 | 40 000 | |||||
2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −2 515 | 143 997 | −1,72 | 48,44 | −121 827 | 6 975 215 | |
2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 6 938 | 146 512 | 4,97 | ||||
2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 875 | 20 125 | −12,50 | ||||
2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 062 | 20 313 | −16,66 | ||||
2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −3 440 | 139 574 | −2,41 | 43,15 | −148 436 | 6 022 618 | |
2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 6 937 | 143 014 | 5,10 | ||||
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 2 675 | −18,35 | ||||
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 2 675 | −18,35 | ||||
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −198 | 74 964 | −0,26 | ||||
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 136 077 | −1,02 | 48,25 | −67 550 | 6 565 715 |
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 477 | 0,44 | 3,40 | 2 043 | 467 422 | |
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 477 | 0,44 | 3,40 | 2 043 | 467 422 | |
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 136 275 | 0,15 | 3,40 | 673 | 463 335 | |
2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 136 077 | −1,16 | 48,25 | −77 200 | 6 565 715 |
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 3 276 | −15,50 | ||||
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 3 276 | −15,50 | ||||
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −198 | 75 162 | −0,26 | ||||
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 137 677 | −1,01 | 45,50 | −63 700 | 6 264 304 |
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 077 | 0,43 | 3,40 | 2 043 | 472 862 | |
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 077 | 0,43 | 3,40 | 2 043 | 472 862 | |
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 137 875 | 0,14 | 3,40 | 673 | 468 775 | |
2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 137 677 | −1,15 | 45,50 | −72 800 | 6 264 304 |
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 3 877 | −13,42 | ||||
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 3 877 | −13,42 | ||||
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −198 | 75 360 | −0,26 | ||||
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 139 277 | −1,00 | 54,15 | −75 810 | 7 541 850 |
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 140 677 | 0,43 | 3,40 | 2 043 | 478 302 | |
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 140 677 | 0,43 | 3,40 | 2 043 | 478 302 | |
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 139 475 | 0,14 | 3,40 | 673 | 474 215 | |
2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 139 277 | −1,14 | 54,15 | −86 640 | 7 541 850 |
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 4 478 | −11,83 | ||||
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −601 | 4 478 | −11,83 | ||||
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −198 | 75 558 | −0,26 | ||||
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 140 877 | −0,98 | 62,95 | −88 130 | 8 868 207 |
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 142 277 | 0,42 | 3,40 | 2 043 | 483 742 | |
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 142 277 | 0,42 | 3,40 | 2 043 | 483 742 | |
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 141 075 | 0,14 | 3,40 | 673 | 479 655 | |
2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 140 877 | −1,12 | 62,95 | −100 720 | 8 868 207 |
2018-02-16 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 000 | 7 000 | −22,22 | ||||
2018-02-16 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −692 | 142 477 | −0,48 | 62,30 | −43 112 | 8 876 317 | |
2018-02-16 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 143 169 | 1,42 | ||||
2018-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 676 | 135 931 | 0,50 | 13,69 | 9 254 | 1 860 895 | |
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 23 000 | 23 000 | |||||
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 35 000 | 35 000 | |||||
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 063 | 24 375 | −14,29 | ||||
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −1 405 | 140 058 | −0,99 | 59,60 | −83 738 | 8 347 457 | |
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 4 063 | 141 463 | 2,96 | ||||
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 000 | 9 000 | −18,18 | ||||
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −692 | 137 400 | −0,50 | 57,90 | −40 067 | 7 955 460 | |
2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 138 092 | 1,47 | ||||
2018-01-26 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 000 | 11 000 | −15,38 | ||||
2018-01-26 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −686 | 136 092 | −0,50 | 58,15 | −39 891 | 7 913 750 | |
2018-01-26 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 136 778 | 1,48 | ||||
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −601 | 5 079 | −10,58 | ||||
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −601 | 5 079 | −10,58 | ||||
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −198 | 75 756 | −0,26 | ||||
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 134 778 | −1,17 | 52,85 | −84 560 | 7 123 017 |
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 136 378 | −1,02 | 52,85 | −73 990 | 7 207 577 |
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 778 | 0,44 | 3,40 | 2 043 | 468 445 | |
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 778 | 0,44 | 3,40 | 2 043 | 468 445 | |
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 136 576 | 0,15 | 3,40 | 673 | 464 358 | |
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −2 000 | 13 000 | −13,33 | ||||
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −877 | 136 378 | −0,64 | 52,10 | −45 692 | 7 105 294 | |
2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 137 255 | 1,48 | ||||
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 5 680 | −9,57 | ||||
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 5 680 | −9,57 | ||||
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −198 | 75 954 | −0,26 | ||||
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 135 255 | −1,02 | 36,55 | −51 170 | 4 943 570 |
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 136 655 | 0,44 | 3,40 | 2 043 | 464 627 | |
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 136 655 | 0,44 | 3,40 | 2 043 | 464 627 | |
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 135 453 | 0,15 | 3,40 | 673 | 460 540 | |
2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 135 255 | −1,17 | 36,55 | −58 480 | 4 943 570 |
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 6 281 | −8,73 | ||||
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 6 281 | −8,73 | ||||
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −198 | 76 152 | −0,26 | ||||
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 136 855 | −1,01 | 39,75 | −55 650 | 5 439 986 |
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 138 255 | 0,44 | 3,40 | 2 043 | 470 067 | |
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 138 255 | 0,44 | 3,40 | 2 043 | 470 067 | |
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 137 053 | 0,14 | 3,40 | 673 | 465 980 | |
2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 136 855 | −1,16 | 39,75 | −63 600 | 5 439 986 |
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 6 882 | −8,03 | ||||
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 6 882 | −8,03 | ||||
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −198 | 76 350 | −0,26 | ||||
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 138 455 | −1,00 | 32,65 | −45 710 | 4 520 556 |
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 855 | 0,43 | 3,40 | 2 043 | 475 507 | |
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 855 | 0,43 | 3,40 | 2 043 | 475 507 | |
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 138 653 | 0,14 | 3,40 | 673 | 471 420 | |
2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 138 455 | −1,14 | 32,65 | −52 240 | 4 520 556 |
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 7 483 | −7,43 | ||||
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 7 483 | −7,43 | ||||
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −198 | 76 548 | −0,26 | ||||
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 140 055 | −0,99 | 30,00 | −42 000 | 4 201 650 |
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 141 455 | 0,43 | 3,40 | 2 043 | 480 947 | |
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 141 455 | 0,43 | 3,40 | 2 043 | 480 947 | |
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 140 253 | 0,14 | 3,40 | 673 | 476 860 | |
2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 140 055 | −1,13 | 30,00 | −48 000 | 4 201 650 |
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 8 084 | −6,92 | ||||
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 8 084 | −6,92 | ||||
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −198 | 76 746 | −0,26 | ||||
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 141 655 | −0,98 | 30,00 | −42 000 | 4 249 650 |
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 143 055 | 0,42 | 3,40 | 2 043 | 486 387 | |
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 143 055 | 0,42 | 3,40 | 2 043 | 486 387 | |
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 141 853 | 0,14 | 3,40 | 673 | 482 300 | |
2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 141 655 | −1,12 | 30,00 | −48 000 | 4 249 650 |
2017-08-14 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 15 000 | 15 000 | |||||
2017-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | −4 062 | 28 438 | −12,50 | ||||
2017-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | −1 527 | 145 790 | −1,04 | 25,10 | −38 328 | 3 659 329 | |
2017-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 4 062 | 147 317 | 2,84 | ||||
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 8 685 | −6,47 | ||||
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −601 | 8 685 | −6,47 | ||||
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −198 | 76 944 | −0,26 | ||||
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 143 255 | −0,97 | 30,00 | −42 000 | 4 297 650 |
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 144 655 | 0,42 | 3,40 | 2 043 | 491 827 | |
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 144 655 | 0,42 | 3,40 | 2 043 | 491 827 | |
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 143 453 | 0,14 | 3,40 | 673 | 487 740 | |
2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 143 255 | −1,10 | 30,00 | −48 000 | 4 297 650 |
2017-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 658 | 144 855 | 0,46 | 13,73 | 9 034 | 1 988 859 | |
2017-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 591 | 144 197 | 0,41 | 15,20 | 8 983 | 2 191 794 | |
2017-01-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
2017-01-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 32 500 | 32 500 | |||||
2016-10-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 9 286 | 9 286 | |||||
2016-03-14 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 9 286 | 9 286 | |||||
2016-03-14 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 749 | 143 606 | 0,52 | 16,09 | 12 051 | 2 310 621 | |
2016-03-14 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
P - Purchase | 25 000 | 25 000 | 20,00 | 500 000 | 500 000 | ||
2016-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 749 | 168 606 | 0,45 | 16,09 | 12 051 | 2 712 871 | |
2016-01-07 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
P - Purchase | 25 000 | 167 857 | 17,50 | 20,00 | 500 000 | 3 357 140 | |
2015-08-11 | 3 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
285 714 | ||||||||
2015-08-11 | 3 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
285 714 |